US 12031157
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted A61KA61K2039/5158A61K35/17
Quick answer
US patent 12031157 (Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/5158, A61K35/17, A61K39/0011